CNT3D has been established as a cutting-edge research center focused on applying breakthrough technologies in synthetic and medicinal chemistry, structural biology, computational chemistry, and machine learning/AI to drug discovery and development (3D).
The center is animated by a multidisciplinary group of Dornsife PIs, who lead the development and application of advanced 3D platforms to address a wide range of targets and therapeutic indications.
CNT3D goal is to serve USC biomedical community by facilitating cost-effective and well-curated entry points into drug discovery at the molecular level.
Featured News & Events:
FEBRUARY 23rd, 2024, 10AM – 5PM
LOCATION:
Michelson Center for Convergent Bioscience — MCB 101
1002 Childs Way, Los Angeles, CA 90089-3502
Organized by CNT3D, MESH Academy and Bridge Institute
Please RSVP to attend:
https://usc.qualtrics.com/jfe/form/SV_bmaKDPH7CPZ9Ydo
USC Today
April 26, 2023, by Leigh Hopper
USC’s Vsevolod “Seva” Katritch discusses how structure-based virtual screening and AI could disrupt the time-consuming, expensive process of drug discovery.
1st Drug Discovery Innovation Workshop
FEBRUARY 24TH, 2023, 10AM – 5PM
LOCATION:
Michelson Center for Convergent Bioscience — MCB 101
1002 Childs Way, Los Angeles, CA 90089-3502
Organized by CNT3D, MESH Academy and Bridge Institute
Scientists aim to catalyze USC drug discovery using workshops and new technology
USC Today
February 22, 2023
By Emily Gersema
Scientists at USC Dornsife and the USC Michelson Center for Convergent Bioscience are hoping to spark drug research across the university by hosting a series of workshops starting Friday.
